STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

CERS CERUS CORPORATION StockScouter® Report

3

StockScouter® Score

CERUS CORPORATION, a small cap growth company in the healthcare sector, is expected to slightly underperform the market over the next six months with slightly higher than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • The most recent quarterly earnings report was significantly higher than analysts’ consensus forecast. Positive

 

Concerns

  • Two or more executives, board directors or major shareholders – including one high-level executive -- sold a large number of shares recently. Very negative
  • One or more analysts has modestly decreased quarterly earnings estimates for CERS. Negative
  • Short-term relative price momentum exhibits meaningful weakness. Negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that small cap stocks will be out of favor, growth stocks will be out of favor, and healthcare stocks will be out of favor.

Expected Risk/Return

Progress: 80% done.
Progress: 40% done.
Low
High

Core Model Grades

C
F
C
C

Previous Ratings

4
6
5